179 related articles for article (PubMed ID: 24492232)
1. [Evaluation of the association between the use of oral anti-hyperglycemic agents and hypoglycemia in Japan by data mining of the Japanese Adverse Drug Event Report (JADER) database].
Umetsu R; Nishibata Y; Abe J; Suzuki Y; Hara H; Nagasawa H; Kinosada Y; Nakamura M
Yakugaku Zasshi; 2014; 134(2):299-304. PubMed ID: 24492232
[TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetic agents in type 2 diabetes.
Levetan C
Curr Med Res Opin; 2007 Apr; 23(4):945-52. PubMed ID: 17407651
[TBL] [Abstract][Full Text] [Related]
3. Impact of the sitagliptin alert on prescription of oral antihyperglycemic drugs in Japan.
Sato D; Sato Y; Masuda S; Kimura H
Int J Clin Pharm; 2012 Dec; 34(6):917-24. PubMed ID: 22941471
[TBL] [Abstract][Full Text] [Related]
4. Risk of Hypoglycemia After Concomitant Use of Antidiabetic, Antihypertensive, and Antihyperlipidemic Medications: A Database Study.
Gosho M
J Clin Pharmacol; 2018 Oct; 58(10):1324-1331. PubMed ID: 29762878
[TBL] [Abstract][Full Text] [Related]
5. Type 2 diabetes and oral antihyperglycemic drugs.
Mizuno CS; Chittiboyina AG; Kurtz TW; Pershadsingh HA; Avery MA
Curr Med Chem; 2008; 15(1):61-74. PubMed ID: 18220763
[TBL] [Abstract][Full Text] [Related]
6. Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus.
Sun GE; Wells BJ; Yip K; Zimmerman R; Raghavan D; Kattan MW; Kashyap SR
Diabetes Obes Metab; 2014 Mar; 16(3):276-83. PubMed ID: 24199848
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycemia Associated with Antibiotics Alone and in Combination with Sulfonylureas and Meglitinides: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS).
Kennedy KE; Teng C; Patek TM; Frei CR
Drug Saf; 2020 Apr; 43(4):363-369. PubMed ID: 31863282
[TBL] [Abstract][Full Text] [Related]
8. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
Fisman EZ; Tenenbaum A; Motro M; Adler Y
Herz; 2004 May; 29(3):290-8. PubMed ID: 15167955
[TBL] [Abstract][Full Text] [Related]
9. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
[No Abstract] [Full Text] [Related]
10. Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database.
Tanabe M; Motonaga R; Terawaki Y; Nomiyama T; Yanase T
J Diabetes Investig; 2017 Mar; 8(2):227-234. PubMed ID: 27549920
[TBL] [Abstract][Full Text] [Related]
11. Reduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database.
Tanabe M; Nomiyama T; Motonaga R; Murase K; Yanase T
BMC Endocr Disord; 2015 Sep; 15():49. PubMed ID: 26382923
[TBL] [Abstract][Full Text] [Related]
12. Suicide attempt by an overdose of sitagliptin, an oral hypoglycemic agent: a case report and a review of the literature.
Furukawa S; Kumagi T; Miyake T; Ueda T; Niiya T; Nishino K; Murakami S; Murakami M; Matsuura B; Onji M
Endocr J; 2012; 59(4):329-33. PubMed ID: 22277726
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.
Aravind SR; Ismail SB; Balamurugan R; Gupta JB; Wadhwa T; Loh SM; Suryawanshi S; Davies MJ; Girman CJ; Katzeff HL; Radican L; Engel SS; Wolthers T
Curr Med Res Opin; 2012 Aug; 28(8):1289-96. PubMed ID: 22738801
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
[TBL] [Abstract][Full Text] [Related]
15. Bullous Pemphigoid and Diabetes medications: A disproportionality analysis based on the FDA Adverse Event Reporting System.
Huang L; Liu Y; Li H; Huang W; Geng R; Tang Z; Jiang Y
Int J Med Sci; 2021; 18(9):1946-1952. PubMed ID: 33850463
[No Abstract] [Full Text] [Related]
16. Emergency management of oral hypoglycemic drug toxicity.
Rowden AK; Fasano CJ
Emerg Med Clin North Am; 2007 May; 25(2):347-56; abstract viii. PubMed ID: 17482024
[TBL] [Abstract][Full Text] [Related]
17. [Adverse effects of oral hypoglycemic agents].
Mori Y; Sekihara H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():325-31. PubMed ID: 12387013
[No Abstract] [Full Text] [Related]
18. Risk factors for adverse symptoms during dipeptidyl peptidase-IV inhibitor therapy: a questionnaire-based study carried out by the Japan Pharmaceutical Association Drug Event Monitoring project in Kumamoto Prefecture.
Kajiwara A; Saruwatari J; Sakata M; Morita K; Kita A; Oniki K; Yamamura M; Murase M; Koda H; Hirota S; Ishizuka T; Nakagawa K
Drug Saf; 2013 Oct; 36(10):981-7. PubMed ID: 23743694
[TBL] [Abstract][Full Text] [Related]
19. [Hypoglycemia in the diabetes treatment - risk minimization with dipeptidyl peptidase-4 inhibitors].
Acuña C
Drugs Today (Barc); 2010 Dec; 46 Suppl F():1-12. PubMed ID: 21240332
[TBL] [Abstract][Full Text] [Related]
20. Use of Spontaneous Reporting Systems to Detect Host-Medication Interactions: Sex Differences in Oral Anti-Diabetic Drug-Associated Myocardial Infarction.
Wang SH; Chen WJ; Hsu LY; Chien KL; Wu CS
J Am Heart Assoc; 2018 Nov; 7(22):e008959. PubMed ID: 30571494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
